|
 |
Acute Myelogenous LeukemiaThis page contains recent news articles, when available, and an overview of Acute Myelogenous Leukemia but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.News: Acute Myelogenous Leukemia Nature.comAcute myelogenous leukemia is a complex and heterogeneous disease characterized by an arrest of normal hematopoetic maturation produced by a clone of ... Acute myelogenous leukemia (AML) - Jul 11, 2008 CNN InternationalAcute myelogenous leukemia (AML) is a cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made. ... … Data Using OXi4503 in Acute Myelogenous Leukemia Models at ASH … - Dec 7, 2009 FOXBusinessThe studies were conducted in mouse xenograft and orthotopic models of acute myelogenous leukemia (AML), and showed that OXi4503, a second-generation, ... Acute myelogenous leukemia in a patient with Li–Fraumeni syndrome … - Jan 26, 2006 Nature.comLi–Fraumeni syndrome (LFS) is a genetic predisposition to cancer development at young age. 1, 2, 3 The underlying genetic defect is usually a germline ... … the outcomes of children with acute myelogenous leukemia in either... - Feb 11, 2008 Nature.comChemotherapy versus transplants for acute myelogenous leukemia in second remission. Leukemia 1996; 10: 13–19. | PubMed | ChemPort |. Glucksberg H, Storb R, ... Treatment of Children With Acute Myelogenous Leukemia - Aug 19, 2007 ACS News CenterTreatment of the M3 subtype (acute promyelocytic leukemia, or APL) is slightly different, and is described separately below. Because of the intensity of ... … t(3;21)(p21;q22) in acute myelogenous leukemia preceding a late- … - Jun 22, 2006 Nature.com1 The presence of a late-appearing Ph chromosome in patients with acute myelogenous leukemia (AML) represents a very infrequent occurrence. ... Acute myelogenous leukemia in Chile PINDA protocols 87 and 92 results - Mar 17, 2005 Nature.comCorrespondence: Dr J Quintana, Hospital Luis Calvo Mackenna, Antonio Varas 360, Providencia, Santiago, Chile. Fax: +562 2104075; E-mail: juanquintana@123.cl ... Scientists Decode Set of Cancer Genes - Nov 5, 2008 New York TimesThe woman at Washington University had acute myelogenous leukemia, ... Tests of 187 other patients with acute myelogenous leukemia found that none had the ... Singapore's DBS says CEO has leukemia, to take leave - Jan 28, 2009 ForbesThe bank said Stanley has been diagnosed with 'acute myelogenous leukemia' and has started undergoing medical treatment in Singapore. ... Targeting the most critical cells: approaching leukemia therapy as a ... - Feb 8, 2005 Nature.com...(2004) CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. Cancer Res 64: 2817–2824 ... Multiple pretibial cutaneous relapses of acute myeloblastic leukemia... - Jan 26, 2009 Nature.comAcute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986. Cancer 1989; 63: 2192–2200. | Article | PubMed | ChemPort | ... Acute Myelogenous Leukemia - Nov 21, 2007 Journal of American Medical Association - Journal of American Medical Association...A common complaint about the medical literature that it is difficult to intellectually marry discoveries made in the basic science laboratory with clinical ... … Releases Two New Molecular Tests For Acute Myelogenous Leukemia - May 18, 2006 Medical News Today - Medical News Today (press release)Genzyme Corporation (Nasdaq: GENZ) announced today the availability of two new molecular tests for acute myelogenous leukemia (AML) with the launch of FLT3 ... … Update On Lestaurtinib In Relapsed Acute Myelogenous Leukemia - Jun 20, 2009 Medical News Today - Medical News Today (press release)Cephalon, Inc. (Nasdaq: CEPH) announced results from a pivotal clinical trial of lestaurtinib (CEP-701) in patients with relapsed acute myelogenous leukemia ... Press Release: Acute Lymphoblastic Leukemia Drug Pipeline Report Out ... - Sep 18, 2007 Pay-Per-View - M2 Presswire - HighBeam Research..."Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell ... Press Release: New Leukemia Report: Acute Lymphoblastic, Chronic … - Aug 25, 2009 Pay-Per-View - M2 Presswire - HighBeam ResearchLeukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia(C)1994 . ... Orphan Drug for the treatment of acute myelogenous leukemia (AML) in the United ... Four-time Iditarod champ Butcher fighting cancer - Dec 9, 2005 ESPNThe musher was diagnosed late last week with acute myelogenous leukemia, ... Acute myelogenous leukemia is a cancer of blood-forming tissues of the bone ... Acute myelogenous leukemia (AML) - Jul 11, 2008 MayoClinic.comHousecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, ... Lipoprotein Receptors in Acute Myelogenous Leukemia Failure to Detect... - Apr 1, 2007 Am J Pathology (subscription)The high-affinity degradation of low-density lipoprotein (LDL) is enhanced 3- to 100-fold in leukemic blood cells from patients with acute myelogenous ... … misses Ph III endpoint.(acute myelogenous leukemia drug therapy)(Br... - Dec 18, 2006 Free with registration - Pharma Marketletter - AccessMyLibrary.com...in a Phase III trial in combination with chemotherapy that was conducted in older, previously untreated patients with acute myelogenous leukemia. ... Press Release: Cancer Acute Lymphoblastic Leukemia or Leukemia or … - Jun 22, 2009 Pay-Per-View - M2 Presswire - HighBeam ResearchUnder the terms ... treatment of third-line acute myelogenous leukemia and ... Orphan Drug for the treatment of acute myelogenous leukemia (AML) in the ... Twenty years of Polish experience with three consecutive protocols... - Sep 29, 2005 Nature.comUntil 1983, results of treatment of acute myelogenous leukemia (AML) in Poland with ... Treatment of patients with acute myelogenous leukemia: review of ... … Announces Award of SBIR Grant for Acute Myelogenous Leukemia … - Sep 26, 2006 Genetic Engineering News - Genetic Engineering News (press release)Penn State University's medical school, for the development of a therapeutic vaccine approach for the treatment of acute myelogenous leukemia (AML). ... Toddler With Progressive Proptosis From Acute Myelogenous Leukemia - Mar 1, 2008 Cancer NetworkThe authors are affiliated with the Children's Hospital Los Angeles and the Keck School of Medicine of the University of Southern California. ... Acute myelogenous leukemia. - Sep 1, 2007 Free with registration - SciTech Book News - AccessMyLibrary.comCurrent treatments for acute myelogenous leukemia (AML) have not proven very effective, particularly when patients are elderly or already infirm. ... Leukemia - Sunitinib, an orally available receptor tyrosine kinase... - Aug 6, 2009 Nature.comEffects of 1,25(OH) 2 D 3 on sunitinib-induced differentiation and growth arrest of acute myelogenous leukemia cells. (a) MOLM13 and HL60 cells were ... Cancer strikes 4-time Iditarod champ Butcher - Other sports- nbcsports... - Dec 8, 2005 msnbc.comThe musher was diagnosed late last week with acute myelogenous leukemia, ... Acute myelogenous leukemia is a cancer of blood-forming tissues of the bone ... … in a bone marrow engraftment model of acute myelogenous leukemia - Jun 7, 2007 Nature.comStrategy for the treatment of acute myelogenous leukemia based on folate receptor -targeted liposomal doxorubicin combined with receptor induction using ... Acute Myelogenous Leukemia; PBSCT well tolerated and feasible in … - May 31, 2006 Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones2006 MAY 31 - (NewsRx.com) -- Peripheral blood stem cell transplantation is well tolerated and feasible in patients aged 60 and older with acute myelogenous ... Young Bucs Fan In 'Total Awe' Over Visit With Team - Apr 8, 2008 Pay-Per-View - Tampa Tribune - ProQuest Archiver..."In people with acute myelogenous leukemia, the bone marrow produces immature cells that usually develop into a type of abnormal white blood cell. ... Press Release: Cancer Acute Lymphoblastic Leukemia or Leukemia or … - Mar 15, 2009 Pay-Per-View - M2 Presswire - HighBeam ResearchCancer Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell ... Acute Myelogenous Leukemia; Clinical outcome not affected in pediatric... - Jan 24, 2005 Pay-Per-View - Clinical Trials Week - Factiva, from Dow Jones2005 JAN 24 - (NewsRx.com & NewsRx.net) -- Clinical outcome is not affected in pediatric acute myelogenous leukemia patients with PTPN11 mutations. ... Preclinical targeting of NF-B and FLT3 pathways in AML cells - Jan 31, 2008 Nature.com20 Finally, less primitive acute myelogenous leukemia colony-forming cells (CFU) can be ... AML, acute myeloid leukemia; AML-CFU, acute myelogenous leukemia ... Quantitative assessment of minimal residual disease in acute myeloid ... - Mar 16, 2006 Nature.comCytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254–266. | Article | PubMed | ISI | ChemPort | ... Acute Myelogenous Leukemia; Clinical outcome not affected in pediatric... - Jan 25, 2005 Pay-Per-View - Science Letter - Factiva, from Dow Jones2005 JAN 25 - (NewsRx.com & NewsRx.net) -- Clinical outcome is not affected in pediatric acute myelogenous leukemia patients with PTPN11 mutations. ... … for a Phase I Acute Myelogenous Leukemia and Acute Lymphoblastic … - May 17, 2009 PR.com - PR.com (press release)...a service contract to manage a three-year Phase I study in subjects with relapsed/refractory Acute Myelogenous Leukemia or Acute Lymphoblastic Leukemia. ... Splenectomy: a new treatment option for ALL tumors expressing Hox-11 ... - Aug 16, 2007 Nature.comTo date, cancer stem cells have been identified as causal in some malignancies, such as acute myelogenous leukemia, chronic myelogenous leukemias, ... Acute Myelogenous Leukemia; Clinical outcome not affected in pediatric... - Jan 28, 2005 Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones2005 JAN 28 - (NewsRx.com & NewsRx.net) -- Clinical outcome is not affected in pediatric acute myelogenous leukemia patients with PTPN11 mutations. ... Shoreview's Kay Trapp: Generous to the bone - May 9, 2008 Minneapolis Star-Tribune - Minneapolis Star TribuneKay Trapp's diagnosis this winter with acute myelogenous leukemia made her friends aware of the need for bone marrow donors. The drive in her name, ... Flow cytometric identification of acute myeloid leukemia with limited... - Apr 16, 2009 Nature.comCytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254–266. | Article | PubMed | ISI | ChemPort | ... Post Remission Therapy in Acute Myelogenous Leukemia(AML) - Apr 3, 2006 Gerson Lehrman GroupAgain back to Gene Profiling. >10000 AML cases/year of which we now have a firmer understanding as to molecular markers that can be targeted particularly in ... … Combination Phase I/II Trial of MLN518 in Acute Myelogenous... - Oct 17, 2005 Pay-Per-View - PR Newswire - HighBeam ResearchMedicinal Product for the treatment of acute myelogenous leukemia in the European ... About Third-Line Acute Myelogenous Leukemia and the Phase II/III ... ... More is better with Acute Myelogenous Leukemia (AML) - Dec 22, 2008 Gerson Lehrman GroupI think the results of the study using higher doses of chemotherapy are, as with higher doses of ARA-C, a likely outcome for the study. ... Comparable non-relapse mortality and survival after HLA-identical... - Nov 5, 2007 Nature.com...de Lima M, Giralt S. Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome. ... Battling to Keep Up, In Spite of Cancer - Jul 9, 2006 Washington PostHe has acute myelogenous leukemia. (By Katherine Frey -- The Washington Post). As of mid-June, Brendan's cancer was thought to be in remission, ... Press Release: Pharmion and MethylGene Announce Orphan Drug … - Feb 11, 2008 Pay-Per-View - PR Newswire - HighBeam ResearchAcute Myelogenous Leukemia (AML) Diagnosis The diagnosis of AML and its variants is made ... Article: In patients with acute myelogenous leukemia ... ... Press Release: Structural GenomiX Initiates Phase 2/3 Trial of... - Aug 16, 2005 Pay-Per-View - PR Newswire - HighBeam ResearchStructural GenomiX Initiates Phase 2/3 Trial of Troxatyl for the Treatment of Acute Myelogenous Leukemia. from PR Newswire. Highbeam Research – FREE Trial. This match is one he cannot afford to lose - Nov 29, 2006 St. Petersburg Times - Google News ArchiveJoseph Grimsley, who has acute myelogenous leukemia, gets a hug from his daughter Asia, 9, on Monday at his home in Largo. LARGO In the heat of the- day, ... Event-Free Survival For Leukemia Patients Improved By Vaccine - Dec 10, 2007 Medical News Today - Medical News Today (press release)The Vaccine Company, which makes the PR1 vaccine, is conducting a national Phase III clinical trial for acute myelogenous leukemia. To be eligible for PR1, ... After 21 years together, woman with leukemia marries her love at... - Aug 12, 2009 Pittsburgh Post-Gazette - Pittsburgh Post GazetteAfter Ms. Welle was diagnosed with acute myelogenous leukemia last month, the couple decided it was finally time to tie the knot. The family is from Erie. ... … 1022 Kosan phase change I, USA (AML).(acute myelogenous leukemia)(... - Jun 13, 2005 Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones...generation Hsp90 inhibitor, in patients with acute myelogenous leukemia (AML), acute lymphocytic leukemia (ALL) or chronic myelogenous leukemia (CML). ... Treatment of AML and MDS relapsing after reduced-intensity conditionin... - Jul 5, 2007 Nature.comNatural history of acute myelogenous leukemia (AML)/myelodysplastic syndrome (MDS) relapsing after allogeneic hematopoietic stem cell transplantation (HSCT) ... NPM1 mutations in therapy-related acute myeloid leukemia with … - Feb 14, 2008 Nature.comCytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254–266. | Article | PubMed | ISI | ChemPort | ... Ethan's Road to Hope - Jan 29, 2010 Paris StarEthan was diagnosed with Acute myelogenous leukemia. Because he has Down's syndrome, he was high risk for Acute myelogenous leukemia (AML). ... INNOVIVE Pharmaceuticals Presents Data on Oncology Drug Programs … - Dec 12, 2006 Genetic Engineering News - Genetic Engineering News (press release)Gleevec(R)-resistant or intolerant chronic myelogenous leukemia, and INNO-305, a peptide immunotherapy for the treatment of acute myelogenous leukemia. ... Acute Myelogenous Leukemia 1; Hematopoietic potential of AML1 closely... - Feb 14, 2005 Pay-Per-View - Hematology Week - Factiva, from Dow Jones2005 FEB 14 - (NewsRx.com & NewsRx.net) -- The hematopoietic potential of AML1 is closely related to its transcriptional activity. ... Autologous bone marrow transplantation for children with AML in first... - Jun 11, 2007 Nature.comProspective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol 1993; ... Leukemia under the microscope - Feb 1, 2010 San Diego Union - Tribune - San Diego Union TribuneAcute myelogenous leukemia: More common in adults than in children, and more common in men than in women. It's treated with drugs. ... Article: Research and Markets Offers New Leukemia Report - Aug 26, 2009 Pay-Per-View - Wireless News - HighBeam ResearchLeukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Therapy Area Pipeline Report" report to its offerings. ... MethylGene and Pharmion Announce US Orphan Drug Designation … - Feb 14, 2008 marketwire.comAcute myelogenous leukemia (AML) is a cancer of the blood and bone marrow that is characterized by the rapid proliferation (growth) of abnormal white blood ... Comparative analysis of the effects of sample source and test … - Jun 23, 2005 Nature.comNumerous studies have analyzed the expression and prognostic importance of various proteins in acute myelogenous leukemia (AML). ... Vion Pharmaceuticals Announces Plans to Conduct a Pivotal Phase II … - Jan 31, 2006 RedOrbitTrials of Cloretazine(R) as a single agent in previously untreated elderly acute myelogenous leukemia and high-risk myelodysplastic syndrome, ... Vaccine Improves Event-Free Survival for Leukemia Patients - Dec 12, 2007 webwire.comThe Vaccine Company, which makes the PR1 vaccine, is conducting a national Phase III clinical trial for acute myelogenous leukemia. To be eligible for PR1, ... Should the concern of myelodysplastic syndrome affect the decision of... - Jul 27, 2009 Nature.comTherapy-related myelodysplasia and secondary acute myelogenous leukemia after ... Secondary myelodysplastic syndrome and acute myelogenous leukemia are ... A phase I study of tipifarnib combined with conventional induction... - Dec 18, 2008 Nature.comBaudard M, Marie JP, Cadiou M, Vigui F, Zittoun R. Acute myelogenous leukemia in the elderly: retrospective study of 235 consecutive patients. ... Acute Myelogenous Leukemia 1; Hematopoietic potential of AML1 closely... - Feb 15, 2005 Pay-Per-View - Virus Weekly - Factiva, from Dow Jones2005 FEB 15 - (NewsRx.com & NewsRx.net) -- The hematopoietic potential of AML1 is closely related to its transcriptional activity. ... … Patients: Multidrug Approach Required For Acute Myelogenous... - Oct 8, 2006 Medical News Today - Medical News Today (press release)The research team examined blood and bone marrow samples of 188 adults with acute myelogenous leukemia (AML) and then followed the patients' progress to ... Acute Myelogenous Leukemia; Gene expression profiling can identify … - Feb 4, 2005 Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones2005 FEB 4 - (NewsRx.com & NewsRx.net) -- Gene expression profiling can be used to determine risk groups in children with acute myelogenous leukemia (AML). ... Acute Myelogenous Leukemia 1; Hematopoietic potential of AML1 closely... - Feb 18, 2005 Pay-Per-View - Drug Week - Factiva, from Dow Jones2005 FEB 18 - (NewsRx.com & NewsRx.net) -- The hematopoietic potential of AML1 is closely related to its transcriptional activity. ... Acute Myelogenous Leukemia; Farnesyl transferase inhibitor can help … - Jan 11, 2005 Pay-Per-View - Science Letter - Factiva, from Dow Jones2005 JAN 11 - (NewsRx.com & NewsRx.net) -- An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating ... … postremission therapy in older adults with acute myelogenous... - Jun 9, 2005 Nature.comThe modern era of treatment for acute myelogenous leukemia (AML) began with the introduction of ... Treatment of acute myelogenous leukemia in older adults. ... ONE MAN'S REQUEST: A SELFLESS GIFT OF LIFE - FOR HIMSELF, … - Jun 2, 2007 Pay-Per-View - St. Petersburg Times - ProQuest ArchiverDoctors found another tumor and eventually diagnosed Jeff with a different kind of cancer, acute myelogenous leukemia. Wagner can go into detail about the ... Allogeneic hematopoietic stem-cell transplantation in patients with... - Mar 10, 2005 Nature.comAutologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research ... Acute Myelogenous Leukemia; Farnesyl transferase inhibitor can help … - Jan 15, 2005 Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones2005 JAN 15 - (NewsRx.com & NewsRx.net) -- An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating ... … Inc. Receives US Patent Related to Its Acute Myelogenous Leukemia ... - Oct 7, 2009 FOXBusiness...inhibitors within the Company's Acute Myelogenous Leukemia (AML) program was ... acute myelogenous leukemia, colorectal cancer and Alzheimer's disease. ... Optimizing therapy with methylation inhibitors in myelodysplastic … - Aug 17, 2005 Nature.comA new anticancer drug with effectiveness in acute myelogenous leukemia. Ann Intern Med 85: 237–245. Schiffer CA et al. (1982) Treatment of the blast crisis ... Former Iditarod champ pushes for blood drive - Dec 31, 2005 $2.95 - Kansas City Star - NewsBankAbout 50 cases of acute myelogenous leukemia (AML) are diagnosed in Alaska each year, ... Butcher, 51, was diagnosed with acute myelogenous leukemia Dec. 2. ... Vion Pharmaceuticals Announces Presentation of Interim Data From … - Jun 2, 2008 RedOrbitClinical trials of Cloretazine(R) (VNP40101M) with cytarabine in elderly patients with acute myelogenous leukemia, with temozolomide in brain tumors, ... Woman battles cancer 2nd time ; Bone-marrow donor drive slated - Oct 6, 2005 Pay-Per-View - Colorado Springs Gazette - ProQuest ArchiverAcute myelogenous leukemia results from damage to the DNA of developing cells in the bone marrow. In most cases, the cause is not clear, the Leukemia and ... Rapid and sensitive typing of NPM1 mutations using LNA-mediated PCR … - Sep 7, 2006 Nature.comAcute myelogenous leukemia (AML) is a heterogeneous group of diseases ... Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. ... The role of reduced intensity conditioning allogeneic stem cell … - Apr 21, 2005 Nature.comAutologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research ... MethylGene Initiates Single-Agent Phase II Clinical Trial With its... - Jul 12, 2007 Genetic Engineering News - Genetic Engineering News (press release)...preliminary results for two clinical trials in hematological indications, Hodgkin's lymphoma, myelodysplastic syndromes and acute myelogenous leukemia. ... Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary … - Jun 23, 2005 Nature.comCytoplasmic nucleophosmin (NPM) identifies a subtype of acute myelogenous leukemia with a normal karyotype and NPM1 gene mutations. N Engl J Med 2005; ... … II/III Clinical Trial Of Troxatyl In Third-Line Acute Myelogenous... - Aug 29, 2006 Medical News Today - Medical News Today (press release)About Third-Line Acute Myelogenous Leukemia and the Phase II/III Trial The Phase II/III trial was designed to establish the safety and effectiveness of ... Leukemia burden delays lymphocyte and platelet recovery after allo... - Nov 17, 2008 Nature.comAllogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using ... Pediatric acute myeloid leukemia: international progress and future … - Jul 28, 2005 Nature.comAcute myelogenous leukemia in Chile. Mature results from PINDA protocols 87 and 92. Leukemia 2005, in press. Ravindranath Y, Chang M, Steuber CP, Becton D, ... Loss of the NPM1 gene in myeloid disorders with chromosome 5 … - Dec 8, 2005 Nature.comNucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. Blood 2005; 106: 1419–1422. | Article | PubMed | ISI | ChemPort | ... Acute Myelogenous Leukemia; Genes with prognostic value identified in... - Mar 1, 2005 Pay-Per-View - Cancer Weekly - Factiva, from Dow Jones2005 MAR 1 - (NewsRx.com & NewsRx.net) -- Gene expression patterns with apparent prognostic value have been identified in acute myelogenous leukemias (AMLs) ... Our Cells, Ourselves, and a Lifesaving Bond [Correction 8/25/09] |... - Aug 18, 2009 Pay-Per-View - Washington Post - HighBeam ResearchTwo years ago I was given a diagnosis of acute myelogenous leukemia, a malignancy of the bone marrow, and I was saved by the stem cells of a stranger. ... Motorcyclists raising money for leukemia | Article from The Topeka... - Oct 18, 2006 Pay-Per-View - Topeka Capital-Journal - HighBeam ResearchThe run is named in honor of Daegen Feyh, a 4-year-old boy who died July 17, 2005, of acute myelogenous leukemia, which typically strikes adults and has a ... Uzoma Azuh, 23, sought in vain for donor; Medical student saw need at... - Oct 2, 2006 Pay-Per-View - Toronto Star - Factiva, from Dow JonesThe second-year student at Wayne State University in Detroit was diagnosed with acute myelogenous leukemia last September. The Windsor man, of Nigerian ... Autologous HSC transplant in t-MDS/AML using cells harvested prior to... - Jul 14, 2008 Nature.comDetection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia ... Ferguson in ICU with pneumonia - Feb 6, 2008 $2.95 - Buffalo News - NewsBankFerguson was diagnosed last month with acute myelogenous leukemia and recently ... Acute myelogenous leukemia is cancer that starts inside bone marrow, ... No role for CXCL12–G801A polymorphism in the development of … - Sep 6, 2007 Nature.comCXCR4 is a prognostic marker in acute myelogenous leukemia. Blood 2007; 109: 786–791. | Article | PubMed | ISI | ChemPort |. Crazzolara R, Kreczy A, Mann G, ... Absolute lymphocyte count recovery after induction chemotherapy … - Nov 10, 2005 Nature.comAbsolute lymphocyte count (ALC) recovery postautologous stem cell transplantation is an independent predictor for survival in acute myelogenous leukemia ... Acute Myelogenous Leukemia; Genes with prognostic value identified in... - Mar 4, 2005 Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones2005 MAR 4 - (NewsRx.com & NewsRx.net) -- Gene expression patterns with apparent prognostic value have been identified in acute myelogenous leukemias (AMLs) ... Acute Myelogenous Leukemia; Genes with prognostic value identified in... - Mar 5, 2005 Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones2005 MAR 5 - (NewsRx.com & NewsRx.net) -- Gene expression patterns with apparent prognostic value have been identified in acute myelogenous leukemias (AMLs) ... Leukemia; Reports from the United States, India and Australia add new... - May 15, 2006 Pay-Per-View - Cancer Weekly - Factiva, from Dow JonesSahu and colleagues published their study in American Journal of Hematology (Alteration of p73 in acute myelogenous leukemia. Am J Hematol, 2005;79(1):1-7). ... Causes of Leukemia - May 4, 2007 BuzzleIt is estimated that one in four cases of acute myelogenous leukemia (AML) ... Acute myelogenous leukemia (AML) has been reported after chemotherapy and/or ... Background information on Acute Myelogenous Leukemia [When available] Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a cancer of the myeloid line of blood cells. It is the most commonly diagnosed type of adult leukemia, and is rare among children. These malignant cells called myeloblasts fail to mature into the different types of blood cells, a process called differentiation. If differentiation does not occur, the myeloblasts accumulate and overtake the number of healthy blood cells, spreading into the bloodstream and other vital organs. The lack of healthy blood cells results in symptoms such as anaemia and abnormal bruising. Myeloid leukemias are characterized as "acute" or "chronic" based on how quickly they progress if not treated. Chronic myelogenous leukemia (CML) is often without symptoms and can remain dormant for years before transforming into a blast crisis, which is markedly similar to AML. Search the web for more resources on Acute Myelogenous Leukemia |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
